InnoCore Pharmaceuticals is pleased to announce its participation in the 17th Global Drug Delivery & Formulation (DDF) Summit, taking place on the 18–20 May 2026 at the Maritim proArte Hotel in Berlin. The DDF Summit is one of Europe’s premier conferences for drug delivery, formulation, and device development, bringing together over 400 pharmaceutical leaders, more than 90 industry experts, and over 100 scientific presentations across four high‑impact content streams.
Since its founding in 2009, the DDF Summit has become a central meeting point for professionals advancing drug delivery technologies, fostering collaboration across small molecules, biologics, device development, and technological innovation. The 2026 edition will once again showcase cutting‑edge research and practical solutions that address challenges in formulation science, patient‑centric device design, nanotechnology, and advanced controlled‑release strategies. For InnoCore Pharmaceuticals, specializing in long‑acting injectable drug delivery systems, the DDF Summit provides the ideal environment to exchange insights with formulation experts, and global pharma partners seeking next‑generation delivery platforms.
As demand for patient‑friendly, long‑acting, and scalable drug delivery solutions continues to rise, InnoCore sees the DDF Summit as an essential opportunity to:
By participating in this event, InnoCore reinforces its commitment to enabling safer, more effective, and more convenient therapies for patients worldwide.
We invite conference participants to connect with our team during the summit to explore collaboration opportunities in long‑acting injectables and innovative drug delivery. Visit our booth or contact us through the form below
"*" indicates required fields